Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10.

Immunology Virology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
21 Apr 2023
Historique:
received: 05 12 2022
revised: 12 01 2023
accepted: 03 03 2023
medline: 4 4 2023
entrez: 3 4 2023
pubmed: 4 4 2023
Statut: epublish

Résumé

Rubella virus (RuV) infection during pregnancy can lead to abortion, stillbirth, and embryonic defects, resulting in congenital rubella syndrome (CRS). It is estimated that there are still 100,000 cases of CRS per year in developing regions with a mortality rate of over 30%. The molecular pathomechanisms remain largely unexplored. Placental endothelial cells (EC) are frequently infected with RuV. RuV reduced the angiogenic and migratory capacity of primary human EC, as confirmed by treatment of EC with serum from RuV IgM-positive patients. Next generation sequencing analysis revealed the induction of antiviral interferon (IFN) type I and III and CXCL10. The RuV-induced transcriptional profile resembled the effects of IFN-β treatment. The RuV-mediated inhibition of angiogenesis was reversed by treatment with blocking and neutralizing antibodies targeting CXCL10 and the IFN-β receptor. The data identify an important role for antiviral IFN-mediated induction of CXCL10 in the control of EC function during RuV infection.

Identifiants

pubmed: 37009214
doi: 10.1016/j.isci.2023.106352
pii: S2589-0042(23)00429-7
pmc: PMC10060672
doi:

Types de publication

Journal Article

Langues

eng

Pagination

106352

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Immunity. 2018 Sep 18;49(3):397-412
pubmed: 30231982
Arch Virol. 2017 Feb;162(2):477-486
pubmed: 27807657
Am J Dis Child. 1969 Aug;118(2):178-85
pubmed: 5794813
PLoS One. 2012;7(7):e40812
pubmed: 22815829
Nat Immunol. 2015 Apr;16(4):328-34
pubmed: 25789673
Wkly Epidemiol Rec. 2011 Jul 15;86(29):301-16
pubmed: 21766537
Sci Rep. 2020 Apr 1;10(1):5785
pubmed: 32238853
Reproduction. 2009 Dec;138(6):895-902
pubmed: 19470597
Neurology. 2012 Sep 11;79(11):1130-5
pubmed: 22933738
Am J Reprod Immunol. 2017 Jul;78(1):
pubmed: 28544362
J Matern Fetal Neonatal Med. 2007 Nov;20(11):777-92
pubmed: 17943641
Pediatrics. 1969 Feb;43(2):251-9
pubmed: 4179144
Int J Mol Sci. 2022 Mar 27;23(7):
pubmed: 35409036
J Neurol. 2020 Jun;267(6):1715-1723
pubmed: 32100126
Neurology. 1999 Nov 10;53(8):1622-7
pubmed: 10563602
Placenta. 1985 Jul-Aug;6(4):281-95
pubmed: 3903730
Angiogenesis. 2017 Nov;20(4):505-518
pubmed: 28623423
Circulation. 1967 Oct;36(4):544-54
pubmed: 6041868
Teratology. 1998 Jul;58(1):13-23
pubmed: 9699240
J Pediatr. 1966 Jun;68(6):867-79
pubmed: 5949097
Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i34-i42
pubmed: 30806708
Mem Inst Oswaldo Cruz. 2018 May 14;113(6):e170542
pubmed: 29768624
PLoS One. 2016 Mar 10;11(3):e0149160
pubmed: 26962867
Major Probl Clin Pediatr. 1978;17:237-58
pubmed: 202812
PLoS Pathog. 2015 Nov 20;11(11):e1005264
pubmed: 26588843
J Pediatr. 1967 Nov;71(5):665-75
pubmed: 6054754
J Neurol. 2008 Aug;255(8):1250-3
pubmed: 18677640
Risk Anal. 2016 Jul;36(7):1315-31
pubmed: 25100307
EBioMedicine. 2015 Nov 27;3:86-92
pubmed: 26870820
Neurology. 2010 Nov 16;75(20):1794-802
pubmed: 21079181
Lancet. 2022 Apr 2;399(10332):1336-1346
pubmed: 35367004
Elife. 2021 Jul 13;10:
pubmed: 34253291
Viruses. 2021 Jun 03;13(6):
pubmed: 34205098
BMC Cancer. 2008 Nov 27;8:350
pubmed: 19036168
J Neurol Neurosurg Psychiatry. 2015 May;86(5):587-9
pubmed: 25185209
Science. 2012 Jun 8;336(6086):1317-21
pubmed: 22679098
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Cardiovasc Clin. 1973;5(1):61-80
pubmed: 4589966
PLoS One. 2013 Aug 05;8(8):e73014
pubmed: 23940821
Sci Immunol. 2018 Jan 5;3(19):
pubmed: 29305462
Pathology. 1974 Jul;6(3):215-22
pubmed: 4607215
Birth Defects Res A Clin Mol Teratol. 2010 Jan;88(1):1-8
pubmed: 19697432
Cell Microbiol. 2016 Dec;18(12):1831-1845
pubmed: 27279006
Int J Infect Dis. 2020 May;94:4-11
pubmed: 32081772

Auteurs

Vivien Henschke (V)

Institute of Medical Microbiology and Virology, Medical Faculty, Leipzig University, Leipzig, Germany.

Konstanze Hild (K)

Institute of Medical Microbiology and Virology, Medical Faculty, Leipzig University, Leipzig, Germany.

Erik Schilling (E)

Department of Internal Medicine III, Rheumatology Unit, Medical Faculty, Leipzig University, Leipzig, Germany.

Jan Haas (J)

Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
German Centre for Cardiovascular Research (DZHK), Partner site Heidelberg, Heidelberg, Germany.

Vanina Filipova (V)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103 Leipzig, Germany.

Stephan Erbe (S)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103 Leipzig, Germany.

Roman König (R)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103 Leipzig, Germany.

Judith M Hübschen (JM)

Department of Infection and Immunity, Luxembourg Institute of Health, 29 rue Henri Koch, 4354 Esch-sur-Alzette, Luxembourg.

Ulrich Laufs (U)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103 Leipzig, Germany.

Claudia Claus (C)

Institute of Medical Microbiology and Virology, Medical Faculty, Leipzig University, Leipzig, Germany.

Jes-Niels Boeckel (JN)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, 04103 Leipzig, Germany.

Classifications MeSH